Physician

Srisha Rao, M.D.

According to 2025 Medicare claims, Srisha Rao, M.D. (NPI: 1578548970) practices cardiology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (NPI: 1679666598; TIN: 20-5476847) and primary practice location at 34476-5575.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,902 traditional Medicare patients, billed 17,950 HCPCS/CPT codes, and received $2,198,353 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 17,102 prescription claims across 2,615 beneficiaries totaling $3,769,881 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 14 claims. Open Payments data shows 75 records totaling $1,684. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $918,717 to $2,198,353. Similarly, Part D prescription costs have moved sharply higher in recent years, from $869,512 to $3,769,881. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,441	13,583	$918,717
2016	2,799	15,863	$1,177,064
2017	2,766	16,066	$1,103,523
2018	2,595	14,390	$1,070,405
2019	2,775	15,838	$1,292,342
2020	2,791	13,428	$1,164,889
2021	2,915	14,552	$1,566,458
2022	2,989	14,718	$1,811,710
2023	2,953	15,177	$1,917,109
2024	2,902	17,950	$2,198,353

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,402	10,342	$869,512
2016	1,582	11,292	$1,028,906
2017	1,793	12,292	$1,221,883
2018	1,829	13,262	$1,501,204
2019	1,979	14,315	$1,863,301
2020	2,039	15,070	$2,195,186
2021	2,154	14,669	$2,502,605
2022	2,305	15,425	$3,025,745
2023	2,395	16,025	$3,582,640
2024	2,615	17,102	$3,769,881

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$4,071
2016	N/R	11	$632
2017	N/R	N/R	N/R
2018	14	14	$10,652
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,390	1,406	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,625	2,590	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,574	1,890	$67
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	480	481	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	676	724	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,395	92,844	$1,766,324
Entresto	Sacubitril/Valsartan	409	27,311	$580,373
Xarelto	Rivaroxaban	369	27,363	$492,041
Repatha Sureclick	Evolocumab	217	11,902	$226,602
Farxiga	Dapagliflozin Propanediol	74	6,330	$112,954

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,684	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Srisha Rao, M.D.?

Tedicare shows public-source Medicare data for Srisha Rao, M.D. (NPI 1578548970), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Srisha Rao, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Srisha Rao, M.D.?

Srisha Rao, M.D. is linked to CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (billing NPI 1679666598) in the available physician profile data.

Does Srisha Rao, M.D. have Open Payments data?

Srisha Rao, M.D. has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.